Adams Street Partners is a global private market investment management firm that offers comprehensive solutions for its investors. As one of the independent, employee-owned firms, Adams Street has established a reputation for strong performance, an extensive knowledge base, and a disciplined investment approach that values quality over quantity. For more than 45 years, Adams Street has gained the experience to successfully manage through some of the most challenging investment cycles. The collective knowledge of the Adams Street team works collaboratively to leverage the global resources of the Firm in navigating the complexities of private markets. Its mission as a premier private markets investment manager is to provide world-class investment performance and maintain the confidence of our investors through our deep understanding of the global private marketplace and deliver exemplary client service.
Level 24 Tower 3, China Central Place 77, Jianguo Road, Chaoyang District, Beijing 100025, China
Akers, Jeffrey B.
Partner and Head of Secondary Investments
Stephen Baranowski
Finance Director
Troy Barnett
Partner
Mattias de Beau
Partner
Bremner CFA, Thomas S.
Partner
David Brett
Partner
Gail Carey
Principal
Chung, Frederick
Partner and Head of Credit Underwriting, Private Credit
Jeffrey Diehl
Managing Partner
T. Bondurant French
Executive Chairman
Joseph Goldrick
Partner, Secondary Investments
Terry Gould
Senior Partner, Growth Equity
Doris Guo
Partner
Gregory Holden
Partner
Brijesh Jeevarathnam
Partner and Co-Head, Global Venture Fund Investments
Alex Kessel
Partner - Co-Investments
Ali Lauer
Investor
Justin Lawrence
Principal
Alejandra Lesch
Partner for Operational Due Diligence and Portfolio Monitor
Michael Lynn
General Partner Partner
Malhotra, Saguna R.
Partner
Ross Morrison
Partner
Robin Murray
Partner and Head of Growth Equity Investments
Jamie Raibley
Principal
William Sacher
Partner and Head of Private Credit
Yar-Ping Soo
Partner
Michael Taylor
Partner
Tobias True
Partner
James Walker
COO
Wallwork, Benjamin
Partner
Fred Wang
General Partner
Waslin, Craig D.
Partner
Ling Jen Wu
Principal
Jian Zhang
Partner
233 past transactions
Cyberhaven
Series D in 2025
Cyberhaven is a data security company focused on enhancing the protection of sensitive information from theft and misuse. The company's innovative platform utilizes advanced data tracing technology to analyze billions of events related to each piece of data, allowing for a comprehensive understanding and classification of sensitive information. This capability enables Cyberhaven to protect a wider range of data types in various forms as they move across networks. By assessing internal actions within enterprises, the platform identifies risky behaviors and practices, helping to prevent security breaches. Additionally, it provides full-context data tracing to minimize false positives and negatives, thereby streamlining incident response investigations. Overall, Cyberhaven aims to simplify and strengthen enterprise security, ensuring that organizations can safeguard their critical information effectively.
Highnote
Series B in 2025
Highnote is an embedded finance company that offers a virtual payment platform designed to streamline complex payment processing flows. The platform allows product and engineering teams at digital enterprises to effortlessly integrate virtual and physical payment card capabilities—including prepaid, debit, credit, and charge cards—into their existing systems. By utilizing developer-friendly open APIs, Highnote provides a fully integrated issuer processor, granting businesses the control, flexibility, and speed needed to enhance their digital payment capabilities. This enables merchants and businesses to accelerate growth through effective payment transformation, delivering significant value to users and fostering unique brand differentiation.
Solera Health
Series E in 2025
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect patients, payers, and physicians with community organizations and digital therapeutics companies. Founded in 2015, Solera's platform consolidates diverse healthcare programs into a single marketplace, facilitating increased consumer participation in health management. The company focuses on value-based health solutions, matching users with tailored programs that address a variety of health concerns, including hypertension, obesity, tobacco usage, diabetes prevention, mental health, and more. By linking members to appropriate health technologies and non-clinical healthcare providers, Solera aims to enhance the management and improvement of overall health outcomes for its users.
Zip
Series D in 2024
ZipHQ offers an intelligent purchase request platform that streamlines the process for employees to initiate purchase or vendor requests. The platform simplifies the creation of purchase requests, automatically routing them for approval across various departments, including procurement, finance, IT, and legal. By integrating with major ERP and P2P solutions, it facilitates the generation of purchase requisitions or draft purchase orders. Additionally, ZipHQ recommends preferred vendors and checks against price benchmarks to enhance cost efficiency and compliance. This comprehensive approach reduces the time spent coordinating approvals, ensuring a smooth and efficient purchasing process for organizations.
Level AI
Series C in 2024
Level AI is a company based in Mountain View, California, that is transforming customer contact centers through its advanced conversational intelligence platform. This platform provides real-time insights that empower agents to assist customers efficiently and effectively during interactions. By automating tedious workflows, Level AI enhances the overall customer experience, allowing front-line workers to operate with the speed and intelligence of a supercomputer while maintaining a natural, human approach. The company is supported by prominent investors, including Battery Ventures, ENIAC, and Village Global, reflecting its potential to redefine how businesses manage customer interactions across various marketing channels.
BillionToOne
Series D in 2024
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Nomad Health
Series E in 2024
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.
Cyberhaven
Series C in 2024
Cyberhaven is a data security company focused on enhancing the protection of sensitive information from theft and misuse. The company's innovative platform utilizes advanced data tracing technology to analyze billions of events related to each piece of data, allowing for a comprehensive understanding and classification of sensitive information. This capability enables Cyberhaven to protect a wider range of data types in various forms as they move across networks. By assessing internal actions within enterprises, the platform identifies risky behaviors and practices, helping to prevent security breaches. Additionally, it provides full-context data tracing to minimize false positives and negatives, thereby streamlining incident response investigations. Overall, Cyberhaven aims to simplify and strengthen enterprise security, ensuring that organizations can safeguard their critical information effectively.
Altruist
Series E in 2024
Altruist is dedicated to enhancing the quality, affordability, and accessibility of independent financial advice. The company offers a digital investment platform that streamlines operations for financial advisors, enabling them to serve their clients more efficiently. By automating research and identifying problem areas, the platform allows advisors to provide better guidance, ultimately empowering clients to make informed financial decisions. This approach not only reduces costs for clients but also fosters greater financial confidence, positively impacting the experiences of tens of millions of individuals. Altruist supports a wide network of financial professionals, helping them deliver valuable services to their clients.
Turquoise Health
Series B in 2024
Turquoise Health is a health tech company focused on simplifying healthcare administration to lower costs and reduce complexity. By leveraging data from hospital and payer machine-readable files, the company has created a marketplace that connects patients, providers, and payers. Its platform allows users to browse and compare prices for elective services offered by hospitals, as well as to compare insurance services. This functionality enables individuals to save money on elective treatments and helps healthcare organizations attract both cash-paying and insured patients. Turquoise Health aims to enhance transparency in healthcare pricing, ultimately benefiting all stakeholders involved.
Cato Networks
Venture Round in 2023
Cato Networks Ltd. is a provider of a cloud-based network Security-as-a-Service platform that integrates networking and security solutions for enterprises. Founded in 2015 and headquartered in Tel Aviv, Israel, with additional offices in locations such as California, the United Kingdom, Singapore, Hong Kong, and Australia, the company offers a secure global SD-WAN. Cato's platform connects various enterprise locations, personnel, and data while optimizing application access across all users and locations. Key features include WAN optimization, firewall protection, secure web gateways, and threat protection. Cato Networks enables organizations to reduce costs associated with MPLS, improve performance for global locations and cloud applications, and eliminate the need for branch appliances, all while providing secure internet access and integrating mobile users and cloud data centers into the network seamlessly.
Aircall
Series D in 2023
Aircall is a telecom company that specializes in cloud-based call center software designed to enhance remote communication between businesses and their customers. The platform integrates with existing productivity and helpdesk tools, allowing workplaces to manage phone support efficiently. Aircall's voice system also provides real-time monitoring of individual and team metrics, enabling organizations to make measurable improvements in customer support and sales engagement.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
DispatchHealth
Venture Round in 2022
DispatchHealth Management, LLC specializes in on-demand mobile and virtual healthcare services, aimed at delivering quality care directly to patients in their homes. Founded in 2013 and based in Denver, Colorado, the company provides a wide range of medical services, including evaluations for acute injuries and illnesses, laceration repairs, splinting, and treatment for conditions such as nosebleeds. Additionally, DispatchHealth offers vital medical procedures like Foley catheter and G-tube placements, medication administration, laboratory testing, and outpatient imaging arrangements. With a focus on convenience and integration, the company enhances the capabilities of patients' care teams while striving to reduce healthcare costs.
US Med-Equip
Debt Financing in 2022
US Med-Equip, Inc. is a Houston-based company that specializes in the rental, sale, maintenance, and management of movable medical equipment for hospitals across the United States. Founded in 1995, the company offers a wide range of equipment, including anesthesia machines, beds, defibrillators, EKG machines, and respiratory devices, as well as furnishings like bassinets and recliners. US Med-Equip is recognized for its commitment to customer service, providing 24/7 support and personalized attention. The company is ISO 9001:2015 certified and employs advanced technology for equipment tracking and management, including an online platform called mySMARTS Portal and the STAR Trax Asset Management solution. In addition to rental and sales, US Med-Equip offers services such as biomedical repair, equipment buyouts, and preventative maintenance alerts, ensuring that healthcare providers can effectively manage their medical equipment and enhance patient care.
ClassDojo
Series D in 2022
ClassDojo, Inc. operates an online school communication platform designed to connect teachers, students, and families, fostering community engagement around classroom activities. Founded in 2011 and based in San Francisco, the platform allows educators to share photos, videos, and announcements through a feature called Class Story, as well as facilitating private messaging between teachers and parents. ClassDojo aims to enhance the educational experience by promoting collaboration and communication, helping to create a supportive environment where students can thrive both in the classroom and at home. The company, originally known as Class Twist, Inc., rebranded in December 2017 to emphasize its commitment to revolutionizing education through community building.
Nomad Health
Venture Round in 2022
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.
FalconX
Series D in 2022
FalconX, Ltd. is a cryptocurrency brokerage and digital asset trading platform founded in 2018 and based in San Mateo, California. The company specializes in providing trading solutions for blockchain and fintech sectors, focusing on reliable execution for its clients. Utilizing data science and machine learning, FalconX's platform aims to eliminate slippage and hidden fees, enabling efficient access to cryptocurrency markets. It serves hedge funds, proprietary trading firms, and other institutional clients by facilitating mid-to-large size trades with smart routing across various liquidity sources for optimal pricing.
Reify Health
Series D in 2022
Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.
Remote
Series C in 2022
Remote offers payroll, tax, HR, and compliance solutions tailored for distributed teams. The company has developed a recruiting platform that assists organizations of all sizes in hiring top talent globally. This platform enables human resource executives to recruit individuals without the risk of compliance issues. Additionally, it supports management in project allocation and payment processes, ultimately enhancing productivity and expanding the workforce within client organizations.
BillionToOne
Series C in 2022
BillionToOne Inc. is a precision diagnostics company based in Menlo Park, California, that specializes in molecular testing for prenatal and oncology applications. Established in 2016, the company has developed a patented molecular counter platform capable of detecting and quantifying DNA molecules at an extraordinarily precise level. BillionToOne's flagship product, UNITY, is a noninvasive prenatal screening test that analyzes fetal cell-free DNA from a simple blood sample taken from the mother, allowing for the detection of single-gene disorders such as cystic fibrosis, spinal muscular atrophy, and beta-thalassemia. This innovative approach aims to replace more invasive procedures like amniocentesis, providing a safer and more affordable alternative for expecting mothers, particularly in developing countries. Additionally, the company is focused on oncology, offering tests that can accurately identify actionable mutations and assess tumor burden through blood samples.
Dremio
Series E in 2022
Dremio Corporation, founded in 2015 and based in Santa Clara, California, develops a data lake engine that enhances the efficiency of data analytics. The platform allows users to execute SQL queries directly against data stored in lakes, eliminating the need for traditional data warehouses. By providing tools that streamline and curate data, Dremio accelerates analytical processes for business intelligence, data science, and machine learning applications. Its self-service capabilities empower data engineers, analysts, and scientists to work more productively and independently. Dremio's innovative approach facilitates faster access to insights, enabling organizations to derive greater value from their data without the complexities of data movement or transformation.
Nomad Health
Series D in 2021
Nomad Health, Inc. operates an online marketplace that connects clinicians with freelance and permanent healthcare jobs across the United States. Founded in 2015 and headquartered in New York, the company provides a platform where doctors and nurses can search for job opportunities based on various criteria, including location, pay rate, and medical specialty. By digitizing the healthcare hiring process, Nomad Health simplifies and modernizes staffing in the healthcare sector, allowing healthcare facilities to efficiently find qualified clinicians. The platform also manages digital resumes and credentials, facilitating communication and organization between clinicians and health systems, while assisting with insurance, applications, travel arrangements, and payment processes.
Reify Health
Series C in 2021
Reify Health, Inc., founded in 2010 and based in Baltimore, Maryland, specializes in cloud-based software designed to enhance health behavior change measurement. Catering primarily to the life sciences industry, the company offers solutions that accelerate the development of new therapies by streamlining clinical research processes. Its flagship product, StudyTeam, supports clinical trial teams by improving enrollment timelines and research efficiency. This software provides research sponsors, contract research organizations (CROs), and clinical research sites with valuable insights into enrollment dynamics, allowing them to prioritize efforts that drive successful clinical outcomes. By reducing administrative burdens, Reify Health enables stakeholders to concentrate on activities that deliver the most significant impact on research productivity and budget management.
Visier
Series E in 2021
Visier, Inc. is a provider of cloud-based workforce intelligence solutions designed to assist organizations in managing their human resources effectively. Founded in 2010 and headquartered in Vancouver, Canada, with an additional office in San Jose, California, the company offers a platform that enables HR professionals to retain, recruit, develop, and motivate their workforce. Visier's solutions facilitate access to critical workforce insights through pre-built analytics and interactive visualizations, allowing businesses to address hundreds of key questions related to HR and workforce planning. The platform supports various industries, including healthcare, financial services, technology, energy, manufacturing, and retail. Visier People, one of its primary offerings, emphasizes comprehensive support from a Customer Success team, ensuring ongoing value and insights for clients as they navigate complex workforce challenges.
Aircall
Series D in 2021
Aircall is a telecom company that specializes in cloud-based call center software designed to enhance remote communication between businesses and their customers. The platform integrates with existing productivity and helpdesk tools, allowing workplaces to manage phone support efficiently. Aircall's voice system also provides real-time monitoring of individual and team metrics, enabling organizations to make measurable improvements in customer support and sales engagement.
Iterable
Series E in 2021
Iterable, Inc. operates a consumer growth marketing and user engagement platform tailored for mid-market and enterprise B2C companies. Founded in 2013 and based in San Francisco, the company provides tools that allow marketers to communicate with users across multiple channels, including email, mobile, social media, and web. Its platform features capabilities such as real-time segmentation, automation, customization, and A/B testing. Additionally, Iterable supports engineers in triggering campaigns, managing user event data, and exporting campaign metrics. The company also offers specialized solutions for e-commerce, political marketing, and media companies, helping clients execute campaigns ranging from shopping cart abandonment notifications to transactional messages. By leveraging artificial intelligence and behavior-driven data, Iterable enables organizations to engage customers effectively throughout their lifecycle, enhancing customer interactions and driving growth.
Homeward
Series B in 2021
Homeward enables agents to let customers buy the home they want using an all-cash offer, and then sell their current property at full market value. The company is expanding in Texas, Georgia and Colorado, with plans to offer its solution to agents and home buyers nationwide.
Actium Health
Series B in 2021
Actium Health specializes in enhancing consumer engagement within the healthcare sector by leveraging health-system data intelligence. The company has developed a healthcare customer relationship management platform that utilizes machine learning and predictive analytics to analyze clinical and payer data. This approach allows healthcare providers to identify actionable insights, which can lead to improved patient engagement and retention. By offering AI-driven recommendations tailored to individual needs and personalized activation tools, Actium Health aims to unlock additional value for healthcare organizations. This, in turn, supports the management of high-risk patients, fosters growth in service lines, and cultivates loyalty among patients, ultimately enhancing their lifetime value.
ThreatQuotient
Debt Financing in 2021
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
Mineralys Therapeutics
Series A in 2021
Mineralys Therapeutics is a biopharmaceutical company that provides hypertension treatment. They also bring a targeted approach to the management of hypertension.
ThreatQuotient
Venture Round in 2021
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
Advise Insurance
Series A in 2021
Advise is a Medicare concierge agency that focuses on serving seniors within their community. In addition to helping seniors compare and select health insurance, Advise provides services that support the full spectrum of healthy senior living. Advise Health Holdings also manages and operates Bloom Insurance, a value-based Medicare enrollment platform with licensed agents in all 48 contiguous states.
Redox
Series D in 2021
Redox, Inc. is a healthtech startup incubator and venture capital firm founded in 2014, based in Madison, Wisconsin. The company specializes in early-stage investments in healthcare information technology, including lab information systems and FDA-approved medical devices. Redox accelerates the development and distribution of healthcare software solutions through its full-service integration platform, designed to facilitate secure and efficient data exchange between healthcare delivery organizations and technology vendors. By creating a comprehensive interoperable network, Redox enables these entities to connect and authorize data sharing, ultimately enhancing patient experiences. The firm focuses on removing technical barriers in healthcare systems, standardizing data, and maintaining integrations, allowing vendors and providers to prioritize the delivery of reliable healthcare services.
PerimeterX
Series D in 2021
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
Freeman Spogli
Debt Financing in 2020
Freeman Spogli Management Co., L.P. is a private equity firm established in 1983 and headquartered in Los Angeles, California, with an additional office in New York, New York. The firm specializes in acquiring middle-market companies, focusing primarily on the consumer sector, including retail, restaurants, direct marketing, e-commerce, and consumer products, as well as the distribution sector, particularly wholesale and business-to-business distribution. Freeman Spogli typically invests between $25 million and $500 million in companies with enterprise values ranging from $100 million to $700 million and EBITDA between $10 million and $50 million. The firm seeks to actively participate in the governance of its portfolio companies by securing board seats and may also pursue add-on acquisition opportunities to enhance its investments. The firm primarily targets companies located in North America, with a strong emphasis on the United States.
Robinhood
Series F in 2020
Robinhood Financial LLC is an online and mobile application-based discount stock brokerage that caters to self-directed investors. Founded in 2012 and headquartered in Menlo Park, California, the company offers commission-free trading in stocks, options, exchange-traded funds, and cryptocurrencies. It aims to democratize access to financial markets, encouraging users to manage their finances and invest through its user-friendly platform. Robinhood provides various services, including cryptocurrency trading, dividend reinvestment, fractional shares, and recurring investments. The firm generates revenue by routing user orders to market makers for execution, enabling a modern financial services platform supported by proprietary technology. Robinhood operates as a subsidiary of Robinhood Markets, Inc.
Palvella Therapeutics
Series C in 2020
Palvella Therapeutics, based in Wayne, Pennsylvania, is a clinical-stage biopharmaceutical company established in 2015. It focuses on developing and commercializing targeted therapies for serious and rare genetic skin diseases, specifically genodermatoses. The company's lead product, QTORIN, is a specialized anhydrous gel designed to deliver active ingredients effectively into the skin, addressing the underlying causes of various dermatological conditions. Palvella's pipeline includes candidates aimed at treating microcystic lymphatic malformations and cutaneous venous malformations, utilizing its proprietary QTORIN platform to offer innovative solutions for underserved patient populations.
Aircall
Series C in 2020
Aircall is a telecom company that specializes in cloud-based call center software designed to enhance remote communication between businesses and their customers. The platform integrates with existing productivity and helpdesk tools, allowing workplaces to manage phone support efficiently. Aircall's voice system also provides real-time monitoring of individual and team metrics, enabling organizations to make measurable improvements in customer support and sales engagement.
Couchbase
Series G in 2020
Couchbase, Inc. is a provider of NoSQL databases tailored for enterprises, particularly for web and mobile applications. The company offers a comprehensive Couchbase platform that includes Couchbase Server, a high-performance distributed database, Couchbase Lite, an embedded database for mobile devices, and Couchbase Sync Gateway, which synchronizes data between mobile devices and the cloud. Additionally, Couchbase provides a cloud-native autonomous database management platform through its Kubernetes Operator and a fully-managed Database-as-a-Service (DBaaS) known as Couchbase Cloud. The platform is designed to handle massive data volumes in real time, making it suitable for industries such as social networking, online gaming, advertising, and e-commerce. Headquartered in Santa Clara, California, with an office in Manchester, United Kingdom, Couchbase was founded in 2008 and rebranded from Membase, Inc. in 2011. The company focuses on empowering developers to create innovative and personalized customer experiences through its agile and scalable database solutions.
Homeward
Venture Round in 2020
Homeward enables agents to let customers buy the home they want using an all-cash offer, and then sell their current property at full market value. The company is expanding in Texas, Georgia and Colorado, with plans to offer its solution to agents and home buyers nationwide.
Epirium Bio
Series A in 2019
Epirium Bio, Inc. is a San Diego-based biopharmaceutical company focused on developing therapeutic compounds for cardiovascular diseases, metabolic syndrome, and various conditions related to mitochondrial dysfunction. Founded in 2008 and previously known as Cardero Therapeutics, Epirium Bio utilizes innovative insights into mitochondrial biology and tissue regeneration to create small molecule therapies. The company's research is aimed at enhancing muscle strength and supporting the treatment of neuromuscular and neurodegenerative disorders, including conditions such as muscular dystrophy. Through its novel approaches, Epirium Bio seeks to provide clinically significant solutions for patients suffering from these challenging diseases.
Punchh
Series C in 2019
Punchh Inc. provides a mobile loyalty and engagement platform designed to enhance customer relationships for the restaurant industry. Founded in 2010 and headquartered in San Mateo, California, the company offers a suite of solutions that includes branded mobile applications for loyalty programs, referral incentives, online ordering, and payment processing. By integrating its platform with existing point-of-sale systems and various social networks, Punchh enables restaurants to gather insights into customer behavior and preferences. Its technology employs artificial intelligence and machine learning to create personalized customer experiences, allowing brands to engage effectively and increase customer lifetime value. With a client base that includes nearly 200 global enterprise brands, Punchh operates not only in the United States but also has a presence in Canada, India, the United Kingdom, and Singapore, facilitating a comprehensive approach to customer retention and remarketing across multiple channels.
Icosavax
Series A in 2019
Icosavax, Inc. is a biotechnology company based in Seattle, Washington, founded in 2017. The company specializes in developing vaccines using its innovative virus-like particle (VLP) technology platform, which allows for the multivalent display of complex viral antigens. This technology aims to provide broad and durable protection against various infectious diseases, with an initial focus on life-threatening respiratory illnesses. Icosavax's pipeline includes vaccine candidates targeting respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and SARS-CoV-2. The company is dedicated to advancing its VLP technology to discover, develop, and ultimately commercialize effective vaccines against these infectious diseases.
PerimeterX
Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
VillageMD
Series B in 2019
VillageMD is a healthcare management services company focused on supporting primary care physicians. Founded in 2013 and headquartered in Chicago, Illinois, the company provides a comprehensive platform that includes tools, technology, operations, and staffing support. It collaborates with physician groups, independent practice associations, and health systems to enhance quality of care, improve patient experiences, and reduce costs. VillageMD's services encompass management, clinical innovation, analytics, and value-based contract negotiation, enabling healthcare providers to achieve better clinical outcomes across various populations. The company operates in multiple markets, including Chicago, Georgia, Houston, Indianapolis, Kentucky, Michigan, New Hampshire, and Austin.
MyHealthTeam
Series B in 2019
MyHealthTeam is a software development company that operates a patient social network aimed at supporting individuals with chronic health conditions. The platform facilitates the creation of disease-specific communities where users can connect with others facing similar health challenges. It provides access to medically-approved content, specialist insights, and treatment options, empowering patients to manage their conditions more effectively. Additionally, MyHealthTeam offers research services that inform clinical trial design and enhances patient education through both branded and unbranded programs. By fostering connections and sharing valuable resources, MyHealthTeam enables patients to navigate their health journeys with greater confidence and support.
TurnKey Vacation Rentals
Series E in 2019
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rentals across top travel destinations in the United States. The company aims to deliver a consistent and high-quality experience for guests that parallels that of a fine hotel, while also enhancing the management, marketing, and financial returns for vacation rental homeowners. Utilizing proprietary smart home technology, including digital locks, housekeeping schedulers, and noise monitors, TurnKey collaborates with local teams to ensure exceptional experiences for guests at every property.
Actium Health
Series A in 2019
Actium Health specializes in enhancing consumer engagement within the healthcare sector by leveraging health-system data intelligence. The company has developed a healthcare customer relationship management platform that utilizes machine learning and predictive analytics to analyze clinical and payer data. This approach allows healthcare providers to identify actionable insights, which can lead to improved patient engagement and retention. By offering AI-driven recommendations tailored to individual needs and personalized activation tools, Actium Health aims to unlock additional value for healthcare organizations. This, in turn, supports the management of high-risk patients, fosters growth in service lines, and cultivates loyalty among patients, ultimately enhancing their lifetime value.
Solera Health
Series C in 2019
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect patients, payers, and physicians with community organizations and digital therapeutics companies. Founded in 2015, Solera's platform consolidates diverse healthcare programs into a single marketplace, facilitating increased consumer participation in health management. The company focuses on value-based health solutions, matching users with tailored programs that address a variety of health concerns, including hypertension, obesity, tobacco usage, diabetes prevention, mental health, and more. By linking members to appropriate health technologies and non-clinical healthcare providers, Solera aims to enhance the management and improvement of overall health outcomes for its users.
GoCardless
Series E in 2019
GoCardless Limited provides online payment processing services that facilitate bank-to-bank transfers for businesses. The company offers a range of products, including GoCardless for one-off and recurring payments, GoCardless Pro for creating a recurring payments ecosystem, and Success+, a tool designed to predict and manage payment failures. With connections to over 2,300 banks across Europe, GoCardless enables businesses to collect payments both domestically and internationally while reducing the stress and costs associated with payment collection. Founded in 2011 and headquartered in London, GoCardless has expanded its presence with offices in Paris, Munich, and Melbourne, serving over 75,000 businesses globally. The company aims to leverage bank account data to enhance decision-making and risk management for its clients.
PerimeterX
Series C in 2019
PerimeterX, Inc. is a cybersecurity company that specializes in developing solutions to prevent automated attacks and malicious web behavior. Founded in 2014 and headquartered in San Mateo, California, with additional locations in London, Miami, and a subsidiary in Tel Aviv, the company offers a suite of products aimed at protecting web infrastructure. Its flagship solutions, known as PerimeterX Bot Defender, provide real-time defenses against various types of bot attacks, including those targeting websites, mobile applications, and APIs. By leveraging behavioral analytics and advanced threat detection techniques, PerimeterX helps organizations in sectors such as e-commerce, travel, and media safeguard their digital assets from account abuse, web scraping, and marketing fraud. The company's innovative approach has garnered recognition, including being listed among the top cybersecurity startups and promising artificial intelligence firms.
Inspira Financial
Private Equity Round in 2019
Inspira Financial is a provider of technology-enabled solutions focused on health, wealth, retirement, and benefits, aimed at simplifying the financial journey for individuals and institutions. The company serves over 7 million clients with more than $62 billion in assets under custody, collaborating with thousands of employers, plan sponsors, recordkeepers, and third-party administrators. Inspira Financial offers a range of services, including automatic rollover solutions, health savings accounts, emergency savings funds, and custody services, all designed to help clients effectively plan, save, and invest for a secure future. Through its innovative approach, Inspira Financial is dedicated to improving outcomes for clients and their beneficiaries.
Arctic Wolf
Series C in 2018
Arctic Wolf Networks, Inc. is a cybersecurity company that provides security operations center-as-a-service to businesses, enabling them to manage and mitigate cyber risks effectively. The company offers a range of services, including cloud infrastructure monitoring, software-as-a-service application monitoring, vulnerability assessments, and account takeover risk detection. It also develops the Arctic Wolf Agent, a software tool that collects actionable intelligence from IT environments. Serving industries such as financial services, healthcare, and legal, Arctic Wolf employs a concierge security model, where its engineers work closely with clients to deliver tailored threat detection, response, and ongoing risk management. Founded in 2012 and headquartered in Eden Prairie, Minnesota, the company also has offices in Provo, Utah, and Waterloo, Canada.
Qpex Biopharma
Series A in 2018
Qpex Biopharma develops a pipeline of agents addressing critical needs for the treatment of infectious diseases. It develops multiple antibiotic drugs intended to combat antimicrobial resistance. The company's technology is focused on targeting the treatment of infectious diseases for both inpatient and outpatient cases, deep expertise in the discovery, development and regulatory approval of anti-infective medicines, including an extensive record of working with public/private partnerships focused on new antibiotics to combat antimicrobial resistance, enabling medical businesses optimal use of products and critical needs for the treatment of infectious diseases in the inpatient and outpatient settings. It was founded in 2018 and is headquartered in San Diego, California.
Cirius Therapeutics
Series A in 2018
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company focuses on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. This next-generation insulin sensitizer aims to address the underlying pathophysiology of NASH, a condition characterized by fat accumulation and inflammation in the liver that can lead to severe complications such as cirrhosis and liver cancer. Cirius Therapeutics is committed to providing innovative solutions to healthcare providers for managing liver and metabolic diseases.
Millendo Therapeutics
Venture Round in 2018
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on addressing significant unmet medical needs by creating distinct therapies that improve clinical care. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing the quality of life for patients, families, and caregivers.
TurnKey Vacation Rentals
Series D in 2018
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rentals across top travel destinations in the United States. The company aims to deliver a consistent and high-quality experience for guests that parallels that of a fine hotel, while also enhancing the management, marketing, and financial returns for vacation rental homeowners. Utilizing proprietary smart home technology, including digital locks, housekeeping schedulers, and noise monitors, TurnKey collaborates with local teams to ensure exceptional experiences for guests at every property.
Cofense
Venture Round in 2018
Cofense specializes in phishing detection and response management software, catering to various sectors, including defense, energy, financial services, healthcare, and manufacturing. The company is known for its PhishMe® simulation training, which enhances enterprise-level security awareness among employees. Cofense's Phishing Detection and Response (PDR) platform utilizes a global network of businesses, with over 35 million trained employees actively reporting potential phishing threats. This unique reporting system processes and catalogs thousands of threats daily that often evade traditional email gateway technologies, subsequently eliminating these threats from customers' inboxes. Additionally, Cofense provides services such as penetration testing, social engineering, incident response, and data forensics, enabling organizations to better understand user security behavior, improve their security posture, and reduce the risk of cyber threats.
Dynamic Signal
Series E in 2018
Dynamic Signal Inc. is an employee communication and engagement platform that enhances the connection between organizations and their employees. Founded in 2010 and based in San Bruno, California, the company specializes in employee advocacy programs designed to boost sales, increase brand awareness, and improve operational efficiency while fostering higher employee engagement. The platform facilitates timely and relevant communication, ensuring that employees receive essential enterprise signals across various channels and devices. Dynamic Signal offers a range of services, including influencer recruiting, collaboration support, member rewards, and account management. Its solutions are utilized by hundreds of major enterprises worldwide, including many Fortune 500 companies, to empower employees and drive productivity through effective advocacy.
Partner Therapeutics
Series A in 2018
Partner Therapeutics, Inc. is an oncology company based in Lexington, Massachusetts, dedicated to the development and commercialization of approved and late-stage cancer therapies. The company focuses on improving treatment outcomes and reducing overall healthcare costs for cancer patients through a comprehensive range of therapies, from primary treatments to supportive care. One of its key products is Leukine, which promotes the growth of white blood cells to aid in cancer treatment. Founded in 2017, Partner Therapeutics aims to connect investigators and healthcare professionals in the field of oncology, ensuring effective treatments are accessible to patients at all stages of their cancer journey.
MATRIXX Software
Series C in 2018
MATRIXX Software, Inc. specializes in developing cloud-native digital commerce solutions that enable businesses to transform their operations. The company's modern commerce platform is designed to support global marketplaces and consumption-based services, allowing users to create digital offerings such as voice, data, and new digital services. Its platform enables customers to engage in on-demand purchasing, manage both traditional and modern services, and implement flexible charging options, including prepay and post-pay systems. Serving communications companies, Internet of Things (IoT) providers, and digital service providers worldwide, MATRIXX Software offers a unified converged charging system that enhances operational agility and facilitates the efficient scaling of infrastructure. Founded in 2008, the company is headquartered in Saratoga, California, with additional offices in London, Dubai, and various locations across Asia and Australia.
Therapy Brands
Venture Round in 2018
Therapy Brands is a provider of specialized software solutions for the mental and behavioral health sectors, including substance use recovery and applied behavior analysis. Headquartered in Birmingham, Alabama, the company offers fully integrated practice management and electronic health record (EHR) systems designed to enhance the operational efficiency of healthcare providers. These solutions encompass various functions such as telehealth, revenue cycle management, e-Prescribing, and credit card processing, which collectively help therapists, psychologists, social workers, and counselors reduce administrative burdens and focus more on patient care. By equipping practitioners with effective tools, Therapy Brands aims to improve the quality of care and health outcomes for individuals within these populations.
Atox Bio
Series F in 2017
Atox Bio Inc. is a biotechnology company based in Ness Ziona, Israel, with an additional office in North Carolina. Founded in 2003, the company specializes in developing immunomodulators aimed at treating critically ill patients suffering from severe infections and acute inflammatory conditions. Atox Bio focuses on novel therapies that target multiple pathways within both the adaptive and innate immune responses, which are crucial in managing infectious diseases, inflammatory disorders, and ischemia/reperfusion injuries. The company’s products are designed to address serious medical conditions with high morbidity and mortality, showing promising results in improving patient outcomes and reducing tissue damage during acute inflammatory events.
Outpost Medicine
Series A in 2017
Outpost Medicine, founded in 2016 and based in the United States, focuses on developing innovative therapeutics for urologic and gynecologic diseases and disorders. The company is dedicated to addressing gastrointestinal and urologic conditions, with its lead clinical-stage product candidate, OP-233, aimed at treating stress urinary incontinence (SUI), a condition characterized by involuntary urine loss during physical activities. Additionally, Outpost is working on treatments for overactive bladder (OAB) and irritable bowel syndrome (IBS), reflecting its commitment to advancing healthcare solutions in these areas.
ThreatQuotient
Series C in 2017
ThreatQuotient, Inc. is a cybersecurity company that specializes in developing a threat intelligence platform designed to help organizations effectively manage and respond to cyber threats. Founded in 2013 and headquartered in Reston, Virginia, the company offers its flagship product, ThreatQ, which integrates and correlates various external threat sources with internal security solutions to provide contextualized intelligence. This platform streamlines security operations by reducing noise, prioritizing threats, and facilitating collaboration among teams. It features capabilities such as Indicator Nurturing, which tailors indicators of compromise to specific infrastructures, as well as integrations with existing security tools and processes. ThreatQuotient's solutions support a range of use cases, including incident response and threat hunting, ultimately enhancing the efficiency and effectiveness of security operations. The company has received multiple awards for its product excellence and industry leadership, reflecting its commitment to advancing cybersecurity practices. Additionally, ThreatQuotient operates internationally, with a presence in Germany and Australia.
Fusion Pharmaceuticals
Series A in 2017
Fusion Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company headquartered in Hamilton, Canada, specializing in the development of radiopharmaceuticals as precision medicines for challenging cancers. The company employs its proprietary Targeted Alpha Therapies platform and Fast-Clear linker technology to connect alpha particle-emitting isotopes to antibodies, enabling the selective delivery of therapeutic agents to tumors. Fusion's lead product candidate, FPI-1434, is currently undergoing Phase 1 clinical trials as a monotherapy for solid tumors expressing insulin-like growth factor 1 receptor. Additionally, the company is exploring the use of FPI-1434 in combination with approved checkpoint inhibitors and DNA damage response inhibitors in preclinical studies to enhance anti-tumor activity. Fusion is also advancing another product candidate, FPI-1966, into clinical development for head and neck and bladder cancers that express fibroblast growth factor receptor. Founded in 2014 as a spinout of the Centre for Probe Development and Commercialization, Fusion aims to transform how cancers are treated through innovative radiochemistry techniques.
Lever
Series C in 2017
Lever, Inc. is a talent acquisition platform that offers a comprehensive web application designed to streamline the hiring process for organizations. Based in San Francisco, the company provides a suite of tools that facilitate job postings, employee referrals, communication, decision-making, sourcing, interviews, and reporting. Its flagship product, LeverTRM, combines applicant tracking system (ATS) and customer relationship management (CRM) functionalities, allowing talent teams to effectively manage their hiring goals and foster connections with potential candidates. The platform's features, such as Lever Hire and Lever Nurture, help organizations build a robust talent pipeline and maintain meaningful relationships with candidates. Additionally, Lever Analytics provides customized reports and data visualization to support informed decision-making for hiring managers and executives. With a commitment to inclusivity, Lever aims to reduce hiring bias and has successfully supported the recruitment efforts of over 3,800 global companies.
Solera Health
Series B in 2017
Solera Health, Inc. is a preventive care benefits manager based in Phoenix, Arizona, that operates a technology platform designed to connect patients, payers, and physicians with community organizations and digital therapeutics companies. Founded in 2015, Solera's platform consolidates diverse healthcare programs into a single marketplace, facilitating increased consumer participation in health management. The company focuses on value-based health solutions, matching users with tailored programs that address a variety of health concerns, including hypertension, obesity, tobacco usage, diabetes prevention, mental health, and more. By linking members to appropriate health technologies and non-clinical healthcare providers, Solera aims to enhance the management and improvement of overall health outcomes for its users.
MyHealthTeam
Series A in 2017
MyHealthTeam is a software development company that operates a patient social network aimed at supporting individuals with chronic health conditions. The platform facilitates the creation of disease-specific communities where users can connect with others facing similar health challenges. It provides access to medically-approved content, specialist insights, and treatment options, empowering patients to manage their conditions more effectively. Additionally, MyHealthTeam offers research services that inform clinical trial design and enhances patient education through both branded and unbranded programs. By fostering connections and sharing valuable resources, MyHealthTeam enables patients to navigate their health journeys with greater confidence and support.
Mintigo
Series E in 2017
Mintigo Inc. is a company that develops an artificial intelligence-based customer engagement and predictive analytics platform aimed at enhancing B2B marketing and lead generation. Founded in 2009 and headquartered in San Mateo, California, Mintigo's platform assists businesses in identifying potential purchases by specific customers, thereby enabling more effective marketing strategies. Key features of the platform include predictive ideal customer profile (ICP) discovery, prioritization of fit and buying stages, predictive audience generation, and account-based marketing (ABM) support. The platform also facilitates new pipeline generation, customer marketing upsell and cross-sell opportunities, insight-driven engagement, and sales enablement. Mintigo's clientele includes notable companies such as Getty Images, Oracle, and Red Hat, who utilize its services to enhance their marketing efforts and optimize the sales cycle. As of October 2019, Mintigo operates as a subsidiary of Anaplan, Inc.
Smule
Series H in 2017
Smule, Inc. is a San Francisco-based company that develops music applications aimed at enabling users to create, discover, and enjoy music. Founded in 2008, Smule offers a range of products, including AutoRap, Magic Piano, and I Am T-Pain, which facilitate collaborative music-making experiences. The company's platform connects individuals globally, allowing them to create music together with friends and renowned artists. Through its innovative approach, Smule fosters a vibrant community for music lovers, enhancing the way people interact with and appreciate music.
Snow Software
Venture Round in 2017
Snow Software is changing the way organizations understand and manage their technology consumption. Our technology intelligence platform provides comprehensive visibility and contextual insight across software, SaaS, hardware and cloud. With Snow, IT leaders can effectively optimize resources, enhance performance and enable operational agility in a hybrid world.
Cirius Therapeutics
Series A in 2017
Cirius Therapeutics, Inc. is a clinical-stage pharmaceutical company dedicated to developing and commercializing therapies for liver and metabolic diseases. Founded in 2015 and headquartered in San Diego, California, the company focuses on its lead product candidate, MSDC-0602K, an oral small molecule currently undergoing Phase 2b clinical trials for the treatment of nonalcoholic steatohepatitis (NASH) with fibrosis. This next-generation insulin sensitizer aims to address the underlying pathophysiology of NASH, a condition characterized by fat accumulation and inflammation in the liver that can lead to severe complications such as cirrhosis and liver cancer. Cirius Therapeutics is committed to providing innovative solutions to healthcare providers for managing liver and metabolic diseases.
Visier
Series D in 2017
Visier, Inc. is a provider of cloud-based workforce intelligence solutions designed to assist organizations in managing their human resources effectively. Founded in 2010 and headquartered in Vancouver, Canada, with an additional office in San Jose, California, the company offers a platform that enables HR professionals to retain, recruit, develop, and motivate their workforce. Visier's solutions facilitate access to critical workforce insights through pre-built analytics and interactive visualizations, allowing businesses to address hundreds of key questions related to HR and workforce planning. The platform supports various industries, including healthcare, financial services, technology, energy, manufacturing, and retail. Visier People, one of its primary offerings, emphasizes comprehensive support from a Customer Success team, ensuring ongoing value and insights for clients as they navigate complex workforce challenges.
TurnKey Vacation Rentals
Series C in 2017
TurnKey Vacation Rentals is a full-service property management company specializing in luxury and premium vacation rentals across top travel destinations in the United States. The company aims to deliver a consistent and high-quality experience for guests that parallels that of a fine hotel, while also enhancing the management, marketing, and financial returns for vacation rental homeowners. Utilizing proprietary smart home technology, including digital locks, housekeeping schedulers, and noise monitors, TurnKey collaborates with local teams to ensure exceptional experiences for guests at every property.
Scytl
Series D in 2017
Scytl is a leader in electronic voting and electoral modernization solutions, offering advanced technology that ensures secure, transparent, and auditable electoral processes. Founded in 2001 as a spin-off from a university research group, the company has developed a substantial patent portfolio, holding over 40 international patents related to election security. Scytl's technology employs unique cryptographic protocols, which have been independently audited and verified for compliance with high security standards. Over the last decade, Scytl has managed more than 100,000 electoral events in over 35 countries, including Canada, the United States, and various nations in Europe and Latin America. Headquartered in Barcelona, Spain, Scytl also maintains strategic offices in Canada, the United States, and other locations worldwide. The company has demonstrated significant growth, achieving annual growth rates between 65% and 70%, supported by prominent financial investors.
Included Health
Venture Round in 2017
Included Health is a healthcare company that offers a blend of virtual care, navigation, and community-based services aimed at enhancing the overall healthcare experience. By integrating technology with personalized care, the company provides members with guidance and advocacy for a wide range of health needs, including urgent and primary care, behavioral health, and specialty services. Included Health focuses on ensuring that individuals receive the appropriate care at the right time, utilizing compassionate and data-driven approaches to improve clinical outcomes and member satisfaction. Through its innovative model, Included Health seeks to redefine healthcare accessibility and quality for all individuals.
Tripping.com
Series C in 2016
Tripping.com is the world's largest metasearch platform for home rentals (think: Kayak for Vacation Rentals). With over 10 million local properties in 150,000+ destinations, Tripping.com gives travelers access to the widest selection of vacation homes and short-term rental homes worldwide. The company launched from TechCrunch Disrupt in NYC and has since raised a $1 million Seed round, an undisclosed Series A rumored by Business Insider to be within $5M-$10M, a $16M Series B, and a $35M Series C in December 2016. The company has investors in Silicon Valley, New York, Europe and Asia. To learn more, please visit https://www.tripping.com.
Carecloud
Series C in 2016
CareCloud is a healthcare information technology company that specializes in cloud-based solutions for medical practices. Founded in 2009 and based in Miami, Florida, it offers a comprehensive suite of services including practice management, electronic health records, revenue cycle management, and patient engagement solutions. CareCloud's tools help medical groups improve profitability, streamline workflows, and enhance patient care by providing actionable data insights in real-time. The company serves various healthcare segments such as dermatology, family practice, and urology, managing over $4 billion in annual accounts receivable on its integrated platform. CareCloud also delivers business intelligence, telehealth services, and consulting, making it a key player in transforming the operational and financial aspects of healthcare delivery. As of early 2020, CareCloud operates as a subsidiary of MTBC, Inc.
Sauce Labs
Venture Round in 2016
Sauce Labs Inc. is a leading provider of cloud-based testing solutions for mobile and web applications, headquartered in San Francisco, California, with a data center in Frankfurt, Germany. Founded in 2008, the company offers a comprehensive testing platform that includes automated browser testing, mobile testing, and various testing services for different programming environments. Its flagship product, the Sauce Continuous Testing Cloud, has facilitated over 3 billion tests, enabling businesses to ensure their applications perform optimally across various browsers, operating systems, and devices. By delivering insights into the user experience, Sauce Labs helps organizations enhance software quality, protect their brand reputation, and speed up product delivery. Co-founded by the original creator of Selenium, Sauce Labs maintains strong ties to the open-source community, providing a unique blend of expertise and customer support in the automated testing space.
TrendKite
Series D in 2016
TrendKite is an Austin, Texas-based company founded in 2012, specializing in public relations (PR) analytics software. The company's mission is to assist organizations in understanding public perception and responding effectively. TrendKite's platform provides comprehensive tools for measuring the impact of PR efforts on brand awareness, website traffic, and overall business objectives. It enables users to create automated or customizable dashboards that can swiftly analyze vast amounts of data, streamlining workflow and improving efficiency. The software is designed to help brands and agencies evaluate trends across various media types, generate insightful reports, and focus on the quality of media coverage rather than merely the quantity.
LogRhythm
Venture Round in 2016
LogRhythm, Inc. is a provider of a comprehensive security intelligence and analytics platform that helps organizations manage cyber risks. Its platform integrates next-generation security information and event management (SIEM), log management, network and endpoint forensics, user and entity behavior analytics (UEBA), and security orchestration and automation. This unified approach enables enterprises to efficiently detect, respond to, and mitigate various cyber threats, including ransomware and advanced persistent threats. The platform supports security operations centers (SOCs) by securing both IT and operational technology environments across cloud, physical, and virtual infrastructures. Additionally, LogRhythm offers professional services, compliance solutions, and training to enhance threat detection and response capabilities. Founded in 2003 and headquartered in Boulder, Colorado, LogRhythm serves a diverse range of sectors, including finance, healthcare, and government, both in the United States and internationally.
Smule
Series G in 2016
Smule, Inc. is a San Francisco-based company that develops music applications aimed at enabling users to create, discover, and enjoy music. Founded in 2008, Smule offers a range of products, including AutoRap, Magic Piano, and I Am T-Pain, which facilitate collaborative music-making experiences. The company's platform connects individuals globally, allowing them to create music together with friends and renowned artists. Through its innovative approach, Smule fosters a vibrant community for music lovers, enhancing the way people interact with and appreciate music.
Aptinyx
Series A in 2016
Aptinyx Inc. is a biopharmaceutical company discovering and developing innovative therapies for challenging disorders of the brain and nervous system. Aptinyx has a proven platform for discovering proprietary compounds that work through a novel mechanism: modulation of the NMDA receptor to enhance pathways involved with nerve cell communication. This mechanism has applicability across a number of CNS disorders. Our goal is to rapidly advance our most promising drug candidates into clinical development for indications with high unmet medical need.
Couchbase
Series F in 2016
Couchbase, Inc. is a provider of NoSQL databases tailored for enterprises, particularly for web and mobile applications. The company offers a comprehensive Couchbase platform that includes Couchbase Server, a high-performance distributed database, Couchbase Lite, an embedded database for mobile devices, and Couchbase Sync Gateway, which synchronizes data between mobile devices and the cloud. Additionally, Couchbase provides a cloud-native autonomous database management platform through its Kubernetes Operator and a fully-managed Database-as-a-Service (DBaaS) known as Couchbase Cloud. The platform is designed to handle massive data volumes in real time, making it suitable for industries such as social networking, online gaming, advertising, and e-commerce. Headquartered in Santa Clara, California, with an office in Manchester, United Kingdom, Couchbase was founded in 2008 and rebranded from Membase, Inc. in 2011. The company focuses on empowering developers to create innovative and personalized customer experiences through its agile and scalable database solutions.
Outpost Medicine
Series A in 2016
Outpost Medicine, founded in 2016 and based in the United States, focuses on developing innovative therapeutics for urologic and gynecologic diseases and disorders. The company is dedicated to addressing gastrointestinal and urologic conditions, with its lead clinical-stage product candidate, OP-233, aimed at treating stress urinary incontinence (SUI), a condition characterized by involuntary urine loss during physical activities. Additionally, Outpost is working on treatments for overactive bladder (OAB) and irritable bowel syndrome (IBS), reflecting its commitment to advancing healthcare solutions in these areas.
Millendo Therapeutics
Series B in 2016
Millendo Therapeutics is a biopharmaceutical company dedicated to developing innovative treatments for endocrine diseases resulting from hormone dysregulation. The company focuses on addressing significant unmet medical needs by creating distinct therapies that improve clinical care. By leveraging scientific advancements, Millendo aims to develop novel compounds that can effectively treat complex conditions, ultimately enhancing the quality of life for patients, families, and caregivers.
HealthFinch
Series A in 2016
Healthfinch, Inc. is a healthcare IT company based in Madison, Wisconsin, founded in 2011. It specializes in developing technology that automates and simplifies routine clinical tasks, particularly focused on prescription renewal requests and visit planning. The company's flagship product, the Charlie Practice Automation Platform, integrates seamlessly with major electronic medical record (EMR) systems such as Allscripts, Epic, and athena. This platform leverages EMR data to streamline workflows, assisting healthcare providers in managing prescription refill requests, pre-visit planning, and identifying care gaps. As of July 31, 2020, Healthfinch operates as a subsidiary of Health Catalyst, Inc. Through its innovative solutions, the company aims to enhance the efficiency of clinics and healthcare systems in handling repetitive EMR tasks.
Skybox Security
Venture Round in 2016
Skybox Security, Inc. specializes in cybersecurity management solutions tailored for enterprises. The company offers a range of products designed to enhance security posture, including Skybox Horizon, which provides visibility into the attack surface and indicators of exposure. Skybox Vulnerability Control focuses on context-aware vulnerability management, while Skybox Threat Manager delivers threat intelligence analysis and response capabilities. Additional offerings include Skybox Firewall Assurance for firewall management and compliance, Skybox Change Manager for automated firewall change workflows, and Skybox Network Assurance for network visibility and control. These solutions are designed to help organizations map, prioritize, and remediate vulnerabilities across diverse corporate networks and cloud environments. Founded in 2002 and headquartered in San Jose, California, Skybox Security serves various industries, including financial services, government, energy, technology, telecommunications, and healthcare, with a global presence in multiple regions.
CBANC
Series B in 2015
cbanc Network is an online professional network for bank and credit union professionals. The company also provides tools for financial institutions such as documents, discussions, vendor management, peer group analysis, risk assessment, and more. It aims to keep community financial institutions independent and thriving by empowering their employees to collaborate, share information, and lead the evolution of community banking. cbanc Network was founded in 2009 and is headquartered in Austin, Texas, United States.
Earnest
Series B in 2015
Earnest was built on the principle that getting a loan shouldn’t be difficult for financially responsible people. Earnest offers student loan refinancing and personal loan. It uses its unrivaled technology to consider more than just a credit score; it looks at thousands of data points such as education, saving patterns, investments, and career trajectory. Customers apply online and can manage their account payment preferences with the online dashboard and mobile app. Earnest was founded in 2013, by Louis Beryl and Ben Hutchinson, and had its official launch in early 2014. Earnest raised several rounds of funding from investors including Andreessen Horowitz, Maveron, Battery Ventures, Atlas Ventures, and several others. In 2017, Earnest was acquired by Navient Corp. Navient maintains Earnest as a separate brand while allowing Earnest to be backed by a larger company. Earnest has grown from distributing $8M loans in its first year of business to distributing nearly $2B in student loans and having a roughly $500M loan portfolio in 2017. Earnest has been included in Fast Company’s World’s 50 Most Innovative Companies list. The company lends across the United States in 45 states and the District of Columbia. In August 2017, it was announced that Earnest would open a second office in Salt Lake City, Utah.
MyHealthTeam
Series A in 2015
MyHealthTeam is a software development company that operates a patient social network aimed at supporting individuals with chronic health conditions. The platform facilitates the creation of disease-specific communities where users can connect with others facing similar health challenges. It provides access to medically-approved content, specialist insights, and treatment options, empowering patients to manage their conditions more effectively. Additionally, MyHealthTeam offers research services that inform clinical trial design and enhances patient education through both branded and unbranded programs. By fostering connections and sharing valuable resources, MyHealthTeam enables patients to navigate their health journeys with greater confidence and support.
Corvus Pharmaceuticals
Series B in 2015
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company based in Burlingame, California, dedicated to developing innovative immuno-oncology therapies. The company’s lead product candidate, Ciforadenant (CPI-444), is an oral small molecule antagonist of the A2A receptor and is currently undergoing Phase Ib/2 clinical trials. Additionally, Corvus is advancing CPI-006, an anti-CD73 monoclonal antibody, which is in Phase I/Ib trials aimed at inhibiting adenosine production and stimulating immune responses, as well as investigating its potential for treating COVID-19. Another candidate, CPI-818, is a small molecule that selectively inhibits interleukin-2-inducible T-cell kinase and is also in Phase I/Ib trials. Corvus Pharmaceuticals collaborates strategically with Angel Pharmaceuticals to enhance its pipeline of targeted investigational medicines. Founded in 2014, the company is focused on addressing significant unmet medical needs in cancer treatment and related diseases.
Cybera
Private Equity Round in 2015
Cybera, Inc. is a provider of Security-as-a-Service and networking solutions tailored for distributed enterprises in the United States and internationally. Established in 2000 and based in Franklin, Tennessee, the company offers a software-defined networking platform that combines security and networking functions, facilitating secure connections for multi-location businesses. Cybera's solutions cater to various sectors, including healthcare, retail, hospitality, and financial services, ensuring compliance with regulations such as PCI and HIPAA. By offering a secure application network overlay, Cybera simplifies network management and reduces complexity and costs for its clients. The company's services include endpoint protection and fully managed security solutions, designed to safeguard sensitive corporate data and protect consumers from identity theft. As of December 2020, Cybera operates as a subsidiary of Professional Datasolutions, Inc.
Orbus Therapeutics
Series A in 2015
Orbus Therapeutics, Inc. is a biopharmaceutical company based in Palo Alto, California, established in 2012. The company specializes in the development and commercialization of therapies aimed at treating brain cancers and other rare diseases. Its primary product, Eflornithine, is an orally bioavailable small molecule that acts as a cytostatic agent, specifically targeting recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. Orbus Therapeutics is dedicated to improving health outcomes for patients with life-threatening conditions by developing innovative medicinal products that inhibit tumor growth through the irreversible inhibition of the enzyme ornithine decarboxylase (ODC). The company is actively working on bringing Eflornithine to the North American market.
Apto
Series B in 2015
Apto, Inc. is a company that develops a cloud-based customer relationship and deal management software tailored for commercial real estate brokers. The platform provides tools for managing contacts, properties, listings, and deals, streamlining the entire deal lifecycle from prospecting to closing. Apto's software consolidates, organizes, and securely stores data in the cloud, ensuring that brokers can find, win, and execute deals efficiently while minimizing the risk of overlooking important details. Established in 2011 and headquartered in Denver, Colorado, Apto was previously known as McLabs, LLC.
RadiumOne
Series C in 2015
RadiumOne is a company that specializes in programmatic marketing automation, providing a software platform designed to make big data actionable for digital marketers. Founded in 2009 and headquartered in San Francisco, California, RadiumOne utilizes programmatic advertising to link brands with potential customers by leveraging proprietary data on consumer behaviors, actions, and interests across various web and mobile touchpoints. This approach enables digital marketers to engage customers effectively with relevant and personalized offers, messages, content, and advertisements, enhancing customer engagement across multiple devices and locations.
Chrome River Technologies
Series D in 2015
Chrome River Technologies, Inc. develops automated expense and invoice management solutions. It offers data integrations, fraud management, corporate card reconciliation, expense policy automation, global supports, prudential and systematic risks, billable and non-billable expenses reporting, consulting services, operational expense management, and mobile platform solutions. The company also provides professional services, support services, receipt handling, web applications, and travel spend optimization. Additionally, it offers Chrome River EXPENSE software that controls costs with automated real-time spend policy compliance monitoring and approval routing; Chrome River INVOICE, which automates and simplifies the invoice management process; Chrome River AUDIT that offers secondary review process to catches the errors and eliminate the potential for fraudulent activity; and Chrome River ANALYTICS, which transforms expense spend data into compelling and actionable reports. It serves legal, construction and engineering, consulting, insurance, healthcare, education, manufacturing, non-profit, retail, sports, technology, and transportation industries. Chrome River Technologies, Inc. was founded in 2007 and is based in Los Angeles, California with additional offices in Canada, the United Kingdom, Germany, France, India, and Australia. As of February 28, 2019, Chrome River Technologies, Inc. operates as a subsidiary of Certify Inc.
Smule
Series F in 2015
Smule, Inc. is a San Francisco-based company that develops music applications aimed at enabling users to create, discover, and enjoy music. Founded in 2008, Smule offers a range of products, including AutoRap, Magic Piano, and I Am T-Pain, which facilitate collaborative music-making experiences. The company's platform connects individuals globally, allowing them to create music together with friends and renowned artists. Through its innovative approach, Smule fosters a vibrant community for music lovers, enhancing the way people interact with and appreciate music.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.